IDO1 and depressive disorder: To determine the relationships between the changes in serum levels of TRP and its metabolites and the development of depression in HCV patients undergoing IFN-α therapy, serum KYN/TRP (reflecting IDO1 activity) and 3-HK/KA (reflecting neurotoxic indices) were examined.